In the STEP trials that led to Wegovy approval, approximately 5% of participants reported GERD or acid reflux symptoms, compared to 3% in the placebo group
Practical considerations for patients include: Continue evidence-based Alzheimer's prevention strategies, including cardiovascular risk factor management, regular physical activity, cognitive engagement, social connection, and a heart-healthy diet such as the Mediterranean or MIND diet Maintain optimal control of diabetes and metabolic conditions, as these are established risk factors for cognitive decline regardless of specific medication choices Discuss any cognitive concerns with healthcare providers promptly, as early evaluation and intervention for memory problems can be beneficial Recognize that managing diabetes effectively with any appropriate medication likely provides some cognitive benefit compared to poorly controlled diabetes Red flags requiring urgent medical evaluation include: Sudden confusion or altered mental status Rapid cognitive decline over weeks to months New focal neurological symptoms (weakness, speech changes, vision changes) Falls or loss of consciousness If cognitive concerns arise, patients should typically start with their primary care provider, who may perform initial cognitive screening and laboratory tests to rule out reversible causes before considering referral to neurology, geriatrics, or a memory disorders clinic
Large-scale randomized controlled trials, including the SUSTAIN and STEP trial programs involving thousands of participants, have not identified immunosuppression as an adverse effect of semaglutide therapy
LillyDirect offers Zepbound vials at $299-$449/month as a legitimate alternative
Is a pituitary MRI required before starting sermorelin in a child
Tested firsthand by me OVERALL SCORE Fair Based on our comprehensive hands-on evaluation How we conducted this review Signed up with Noom and purchased GLP-1s firsthand
